Insulin aspart
HealthData.Gov
Updated May 26, 2026
About this dataset
Novolog (insulin aspart) is a fast-acting insulin analog used to control blood sugar in people with diabetes. It's injected subcutaneously or intravenously, available in pens, syringes, and vials at 100 units/mL strength. Manufactured by Novo Nordisk, it's prescribed for managing type 1 or 2 diabetes. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Insulin aspart
Access the FDA dataset for Insulin aspart โ ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025